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Abstract
Background: Healthcare organisations in England rated as inadequate in terms of leadership and one other domain 
enter the Special Measures for Quality (SMQ)  regime to receive increased support and oversight. There is also a ‘watch 
list’ of challenged National Health Service (NHS) providers at risk of going into SMQ that receive support. There is 
limited knowledge about whether the interventions used to deliver this support drive improvements in quality, their 
costs, and whether they strike the right balance between support and scrutiny. The study will seek to determine how 
provider organisations respond to these interventions, and whether and how these interventions impact organisations’ 
capacity to achieve and sustain quality improvements over time. 
Methods: This is a multi-site, mixed methods study. We will carry out interviews at national level to understand the 
programme theory underpinning the interventions. We will conduct 8 NHS case studies to explore the impact and 
implementation of the interventions that form part of the SMQ and challenged providers programme. We will use a 
conceptual framework based on models of organisational readiness for change and draw on board maturity research 
for implementing quality improvement. We will also review the use of quantitative metrics and data for tracking the 
progress of improvements in quality of care and sustainability upon leaving SMQ, as well as the costs and benefits of the 
interventions through a cost-consequence analysis (CCA). 
Discussion: High-quality interventions that successfully support struggling healthcare organisations are essential and 
an issue that is an international concern. Our study will allow a greater understanding of the programme theory, impact, 
and staff views and experiences of the SMQ and challenged providers regime. Formative feedback will be reported to 
key stakeholders.
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Background
There is an internationally recognised need for transparent, 
integrated, and timely processes for identifying quality and 
patient safety issues across healthcare systems.1 There may be 
indications of persistent performance issues in a healthcare 
organisation long before a crisis comes to the attention 
of the public and regulators. Attention has been placed 
on failing healthcare organisations, their characteristics 
and the factors (internal and external) that might lead to 
low performance. These include low leadership capability, 
lack of open culture, antagonistic external relationships,2-4 
inadequate infrastructure, lack of a cohesive mission, and 
system shocks.5 A hierarchical culture and leadership focused 
on avoiding penalties and achieving financial targets - rather 
than a patient-centred mission - are characteristics identified 
in many failing organisations. High-quality interventions 
capable of helping struggling healthcare organisations to 
improve are essential.5 
The Special Measures for Quality (SMQ) regime is a targeted 
and time-limited regime in the National Health Service (NHS) 
in England agreed between the Care Quality Commission 
(CQC) and NHS Improvement (NHSI). The regime emerged 
following the Keogh Review into avoidable mortality in 2013.6 
Trusts are put into SMQ only where serious care quality 
failings are identified and the leadership appear unable to 
resolve the problems without intensive support and external 
input.7-9 The SMQ regime provides trusts with oversight and 
interventions from NHSI, the national regulator, to help them 
address specific quality failings identified in CQC inspections. 
NHSI perceive SMQ as a support regime to bring about 
improvement (correspondence, October 2018). There is also 
a ‘watch list’ of challenged NHS providers at risk of entering 
SMQ that receive support. Unlike SMQ, the challenged 
provider list is not available in the public domain. Interventions 
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for SMQ/challenged providers typically vary between trusts 
and may include appointment of an Improvement Director; 
review of the trust’s leadership capability; access to financial 
resources for quality improvement; an improvement plan, 
including options for diagnostic work on assessing medical 
engagement; buddying with other trusts and commissioning 
external expertise. These may be delivered in conjunction 
with other interventions, and within a context of significant 
senior leadership changes.
Studies of the SMQ regime have highlighted unintended 
consequences for trusts, such as difficulties with recruitment 
and retention, lowering of staff and patient morale, increases 
in financial costs, and external pressures placed on already 
burdened management systems.10 A recent evaluation of the 
CQC inspection regime categorises 8 types of regulatory 
impact arising from the inspection regime (Table 1).11 The 
impact of CQC inspections was found to vary considerably 
according to type and size of provider, although ‘directive,’ 
‘stakeholder’ and ‘organisational’ influences appear most 
applicable to providers that are asked by the regulator to take 
immediate action to improve quality and enter SMQ. 
The Special Measures Regime
We analysed data supplied by NHSI on trusts that had entered 
SMQ since the regime began in July 2013 up to September 
30, 2018. A total of 35 trusts entered SMQ; 4 trusts returned 
to SMQ (giving 39 episodes), 25 had exited SMQ, and as of 
September 30, 2018, there were 14 trusts in SMQ. The “watch 
list” of challenged providers was initiated in July 2015. These 
trusts receive interventions to prevent them entering SMQ. 
On September 30, 2018, there were 17 trusts on this list. Since 
July 2015, 44 trusts have been placed on this list, with 17 trusts 
leaving the list because they entered SMQ, and 1 trust left 
the list and subsequently returned. Fifty-nine trusts entered 
SMQ or the challenged providers list between July 2013 and 
September 2018. As of January 2019, there were 234 trusts 
in England, meaning that roughly one quarter of trusts have 
experience with SMQ or the challenged providers regime 
(Table 2). NHSI also manages a Special Measures for Finance 
programme (SMF), introduced in July 2016. SMF will not be 
examined in this study. 
Study Aims
The study will analyse the responses of providers to the 
implementation of (a) interventions for trusts in SMQ and 
(b) interventions for challenged providers to determine 
their impact on these organisations’ capacity to sustain and 
achieve quality improvements. We will focus on the main 
interventions that NHSI has identified as forming part of the 
SMQ/challenged provider regimes:
1)	 appointment and use of an Improvement Director;
2)	 buddying with other trusts;
3)	 the opportunity to bid for central funding to spend on 
quality improvement. 
We will also include any other interventions participating 
trusts identify as being part of the SMQ/challenged provider 
regimes and consider these interventions within a wider 
context of any leadership changes. We will draw on evidence 
from the academic literature (eg, on organisational failure, 
turnaround and performance) to explore these issues and 
apply a range of appropriate quantitative, economic, and 
qualitative research methods. 
 
Research Questions
1.	 What are the programme theories (central and local) 
guiding the interventions delivered to trusts in SMQ/
challenged provider regimes?
2.	 How and why do trusts respond to SMQ/challenged 
provider regimes and the interventions within these 
regimes?
3.	 Which features of trusts in SMQ/challenged provider 
regimes, and their wider context, contribute to their 
differing performance trajectories?
4.	 What are the relative costs of the interventions and how 
do these compare with their benefits?
5.	 How are data used by trusts in SMQ/challenged 
provider regimes, and how does data contribute to their 
understanding of improvements in quality and service 
delivery, especially in areas where performance concerns 
have been raised by the CQC?
6.	 Do trusts in SMQ/challenged provider regimes find it 
more difficult to recruit and retain staff?
Methods
Study Design
The study is being conducted by the National Institute for 
Health Research (NIHR) - Health Services and Delivery 
Research funded Rapid Service Evaluation Team (RSET); 
Table 1. Eight Regulatory Impact Mechanisms
Impact Mechanism Description 
Anticipatory Providers seek to comply in advance of regulatory interactions (eg, inspection).
Directive Providers take direct actions as requested by the regulator. Legal consequences possible in cases of non-compliance. 
Organisational
Providers instigate internal processes not explicitly related to directives on account of interaction with the regulator, such as 
addressing leadership or culture.
Relational Influence of (human, interpersonal) interactions between regulatory staff and regulated providers.
Informational Regulatory information on performance enters the public domain and informs decision-making.
Stakeholder Other stakeholders take action and interact with the regulated provider.
Lateral Regulatory interaction results in new inter-organisational actions (across boundaries), such as peer learning.
Systemic Regulatory information on providers is used to identify wider issues in systems of care, beyond a single provider.
a Adapted from Smithson et al.11
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a 5 year research programme that aims to rapidly evaluate 
health and care service innovations to produce timely 
findings of national relevance and immediate use to decision-
makers. This is a multi-site, mixed-methods study that will 
combine qualitative and quantitative approaches to analyse 
the implementation of interventions delivered to SMQ/
challenged providers, and the impact of these interventions 
on trust performance, quality of care, patient experience, 
and costs. We will apply a conceptual framework based on 
previous models of organisational readiness for change and 
board maturity for quality improvement. To support the one 
year time frame data collection and analysis will follow a 
rapid research design12 involving: teams of field researchers, 
participatory approaches, and iterative data collection and 
analysis, with the research team meeting fortnightly to discuss 
progress and emergent findings (Figure 1).
Our study consists of 5 inter-related elements:
1. Literature Review Using Systematic Methods 
We will conduct a rapid literature review of organisational 
failure in the public sector following rapid review methodology 
that uses a phased search approach.13 It will build on a recent 
review of organisational failure.5 Rapid reviews follow a 
systematic review approach, but some steps are adapted to 
reduce the time required to complete the review (ie, using 
large teams to review abstracts and full texts, and extract 
data; in lieu of dual screening and selection, a percentage 
of excluded articles are reviewed by a second reviewer, and 
software can be used for data extraction and synthesis13). The 
Table 2. The Types of NHS Trust Entering SMQ or on the Challenged Providers List (July 2013-September 2018)
Trust Type Number of Trusts Ever in SMQ or on Challenged Providers List Trusts in SMQ (at September 2018)
Trusts on Challenged Providers List (at 
September 2018)
Acute services only 33 7 9
Acute and community 18 4 7
Acute and mental health 1 1 0
Ambulance 2 1 0
Community and mental health 1 0 1
Mental health 4 1 0
Total 59 14 17
Abbreviations: NHS, National Health Service; SMQ, Special Measures for Quality.
Study month 
1 2 3 4 5 6 7 8 9 10 11 12 
Literature review - phase 1 Literature review – phase 2    
National interviews           
Exploratory workforce evaluation     
Recruit case study Trusts          
 Case study data collection (qualitative and quantitative)   
    Case study data analysis  
Cost analysis        Cost consequence analysis  
          Write-up of reports 
Fortnightly research team meetings 
 
 
 Figure 1. Study Timeline.
Preferred Reporting Items for Systematic Reviews and Meta-
Analysis (PRISMA) statement will guide the reporting of the 
methods and findings.14 The review protocol is registered 
with PROSPERO (CRD42019131024). 
Review Research Questions
Phase 1
1. How are ‘failing healthcare organisations’ defined?
2. What theoretical approaches have been used to explain 
organisational failure?
3. How is ‘organisational turnaround’ defined?
4. Which theoretical approaches have been used to study 
turnaround strategies (if any)?
Phase 2
1. What are the main interventions delivered to improve 
quality? Who delivers these interventions? 
2. What are the programme theories guiding these 
interventions?
3. What are the main processes of implementation?
4. What is the impact of the implementation of these 
interventions? How are quality and performance 
monitored? 
5. What is the sustainability of improvements produced by 
these interventions (if any)? 
6. Have any of these interventions been evaluated? If so, 
how?
7. What are the costs and potential benefits of these 
interventions? 
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Search Strategy
Phase 1
Broad searches will cover literature from the fields of health 
services research, management and business studies to 
identify overarching themes on regulation, performance and 
quality improvement in healthcare organisations and the 
public sector (for an example of this approach see Ferlie et 
al15). The theoretical content from this literature will be used 
to develop a thematic framework of organisational failure and 
turnaround that will be used to inform the second phase. 
Phase 2
Targeted searches will focus on interventions designed to 
address organisational failure and turnaround in healthcare 
and other public sectors such as education and local 
government settings and interventions delivered to high-
performing organisations. We will search multiple databases: 
MEDLINE, CINAHL PLUS, EMBASE, and Web of Science for 
published literature. Results will be combined into Mendeley 
(Elsevier) and duplicates removed. Reference lists of included 
articles will be screened to identify additional relevant 
publications. We will hand search other relevant databases, 
such as the King’s Fund library, and search for relevant grey 
literature using Open Grey and TRIP. 
Study Selection
Following rapid review methodology,13 one researcher 
will screen article titles, and 3 researchers will cross-check 
exclusions in the abstract and full-text phases. Disagreements 
will be resolved through discussion. Inclusion criteria are: 
(1) focus on delivering interventions in failing organisations, 
defined as not meeting required quality standards (self-
defined or defined by external regulating organisation), 
(2) focus on delivering interventions in high-performing 
organisations (self-defined or defined by external regulating 
organisation), (3) describes empirical research, (4) describes 
research in healthcare and other public sector settings, (5) 
published in last 20 years, and (6) published in English. 
Data Extraction And Management
Included articles will be analysed using a data extraction form 
developed in REDCap (Research Electronic Data Capture). 
The form will be piloted independently by 2 researchers 
using a random sample of 5 articles. Disagreements will be 
discussed until consensus is reached. The data extraction 
form will be finalised based on pilot findings. 
Data Synthesis
Data will be exported from REDCap and the main article 
characteristics synthesised. Information entered in free text 
boxes will be exported from REDCap and analysed using 
framework analysis.16 The thematic framework developed 
Phase 1 will guide our exploration of themes. 
Quality Assessment
We will use the Mixed Methods Appraisal Tool to assess 
article quality.17 Two researchers will rate these articles 
independently. Disagreements will be resolved through 
discussion. Inter-rater reliability will be calculated using the 
kappa statistic.18 
2. Interviews at National Level
We will carry out 5-7 interviews with staff at national 
level. The research team will identify contacts within key 
stakeholder groups, including with NHSI, the CQC and 
the Department of Health and Social Care (DHSC) and ask 
for recommendations for individuals involved in the SMQ/
challenged provider regimes. These individuals will then be 
invited independently to take part in a research interview. 
The purpose of these interviews is to better understand how 
the interventions deployed to support trusts are perceived by 
different stakeholders in relation to their programme theory/
ies (ie, the underlying assumptions and expectations about the 
purpose of the intervention and the anticipated impact), and 
which interventions are viewed as being particularly effective, 
and under what conditions. The interview guide will cover 3 
broad topic areas (1) aims of the SMQ/ challenged provider 
regimes; (2) policy and interventions; and (3) impact. 
3. Multi-site, Mixed Method Case Studies
We will conduct 8 case studies (4 ‘high level,’ 4 ‘in-depth’). 
Case study research is common in management, business 
and organisational research and policy evaluations. Yin 
defines the case study as an ‘in-depth inquiry into a specific 
and complex phenomenon.’19 Case studies typically employ a 
range of data collection methods – quantitative, qualitative or 
a mixture of both – to ‘construct narratives of past events, or 
accounts of specific cases.’20 
Conceptual Framework
Case studies will explore the implementation of interventions 
in SMQ/challenged provider trusts, reflecting on any 
observed changes in processes and outcomes reported across 
specified time points (eg, point of entry into, or exit from, 
SMQ). We will apply a board maturity framework developed 
in previous research, which found that boards with higher 
levels of maturity in relation to governing for quality 
improvement were able to effectively balance short-term 
(external) priorities against long-term (internal) investment 
in quality improvement and engage staff and patients in the 
process of change.21 
In order to understand processes of quality improvement 
beyond board level, especially amongst “clear improvers” 
that exit SMQ and sustain change, we will use the concepts 
of absorptive capacity and dynamic capabilities from the 
strategic management literature to identify any routines 
or processes that have helped staff - from senior leaders to 
frontline clinicians - to learn from external information about 
performance and quality to sustain performance objectives.22 
Absorptive capacity refers to the ability of organisations to 
acquire and exploit new information and knowledge and 
successfully transfer it internally – across organisational sub-
units – to support learning and performance.23 Dynamic 
capabilities refers to patterned activities and routines that 
require dedicated resources and long-term commitment 
to effect impactful change.24 Applying such concepts will 
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help to distinguish between evidence of incremental or ad 
hoc changes in trusts arising from externally driven SMQ 
interventions, and more radical or novel service innovations 
that improve quality and trust performance and have become 
embedded in new ways of working over time at trusts. 
Trust Sampling Framework
Inclusion criteria
•	 NHS trusts (ambulance, acute, mental health and/
or community providers) placed in SMQ and/or the 
challenged providers regime before September 30, 2018.
Exclusion criteria
•	 Trusts placed in SMQ and/or the challenged providers 
regime (for the first time) after September 30, 2018.
•	 Trusts placed in SMF only and never in SMQ or the 
challenged providers regime.
Fifty-nine trusts meet our inclusion criteria (Table 2). 
Performance trajectories for these trusts were determined 
based on amount of time spent in SMQ/challenged provider 
regimes, and progress over time (Table 3). 
Trust Sampling Strategy 
The overall objective of the case studies is to understand 
dynamics within trusts and their local contexts at different 
ends of the performance spectrum. To do this we will 
purposively sample 8 case study sites, with 2 sites from each 
performance category (Figure 2). We will attempt to account 
for provider size and type to ensure a range of organisations.
(i) Qualitative Fieldwork
Data Collection
Qualitative fieldwork will combine semi-structured 
interviews, meeting observations, and documentary analysis 
(Table 4). Interviews and observations will document 
processes used to implement the interventions based on 
available data to plot a chronology of the quality improvement 
changes at each site. We will note internal (inner) and external 
(outer) contextual factors potentially influencing participation 
in the interventions, including senior level leadership 
changes and perceptions from the wider community and 
stakeholders in the local heath economy. We will remain open 
to understanding the interventions trusts perceive to be part 
of SMQ/challenged provider regimes, in addition to those 
identified by NHSI as being effective for driving change.
To aid the quantitative analysis, we will study how people 
within trusts use data with an emphasis on whether and 
how data are used to track improvements in quality of care. 
To facilitate the economic analysis, we will query resource 
use and costs incurred by the different interventions, their 
perceived impacts on quality, and additional unintended 
consequences (positive or negative). 
Documentary analysis will identify organisational 
strategies and variables that appear to indicate change over 
time (ie, since point of entry into SMQ) - such as shifts in 
organisational composition (eg, workforce numbers and 
vacancy levels) and changes in organisational structure (eg, 
new governance systems or mergers). This analysis will also 
seek to compare central and local theories guiding quality 
improvement efforts. Throughout the data collection process, 
the data will be summarised in the form of RAP (Rapid 
Assessment Procedures) sheets. The RAP sheets will facilitate 
consistency in data collection across 3 qualitative researchers 
and will allow the team to identify gaps in data collection that 
need to be addressed before the fieldwork ends. 
Sampling
Participants
We propose to use “vertical slicing” in the 4 ‘in-depth’ sites, 
conducting interviews across different organisational tiers as 
well as with external stakeholders, including patient groups. 
Up to 15 interviews will be completed at each in-depth case 
study site. The types of interviewees will depend on the 
context of each trust, but are likely to include divisional/
clinical directors, and may include staff from a clinical unit 
which the CQC has flagged as ‘inadequate.’ In the 4 ‘high-
level’ sites, we will conduct 8-10 interviews at the ‘top’ of the 
organisation and with key external stakeholders. 
Non-participant Observations
We will observe public Trust board meetings and quality 
Table 3. Descriptions of Performance Categories
Performance Categorya Performance Category Description Trusts Matching Descriptionb
‘Prolonged poor performers’
Trusts that have been in SMQ for 2 years or longer since the introduction of the 
regime, including those trusts that re-enter SMQ after a period of exit. 
19
‘Poor performers’ Challenged providers who end up in SMQ. 12
‘Shorter term challenged 
providers’
Challenged providers who avoid entry into SMQ and have not previously been placed 
in SMQ. This may include trusts that merged with higher performing providers. They 
are or were ‘challenged’ for less than 2 years.
20
‘Clear performance improvers’
Trusts that have previously entered SMQ or been on the challenged providers list but 
later achieved a good or outstanding overall CQC rating, without re-entry into either 
regime.  
9
Other trusts
Trusts that do not meet any of the other criteria (4 because they were ‘challenged’ 
for a longer time, and one because they left SMQ after a short period but have never 
been rated good or outstanding by CQC). These trusts were not sampled.
5
Abbreviations: CQC, Care Quality Commission; SMQ, Special Measures for Quality.
a Performance categories are neither exhaustive nor mutually exclusive.
b Some trusts fit multiple categories.
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or performance-focused meetings at divisional level, after 
securing prior permission, at the 4 ‘in-depth’ sites and 
gaining individual consent from participants at the time of 
the meeting. We will use the board quality improvement 
maturity framework21 in our observations of boards and 
other relevant meetings to support analysis of observational 
data. We will focus on critical quality incidents or service 
issues where progress in quality improvement appears 
‘transparently observable’ or where improvements are 
proving especially challenging for the organisations.25 Thus, 
we might study a particular clinical unit that has been flagged 
as in need for improvement in earlier CQC inspections or 
a new intervention the trust has introduced to support staff 
engagement in quality improvement, such as ‘quality huddles.’
Documents
We will collect documents on SMQ/challenge provider regimes 
produced centrally (eg, by the DHSC or NHSI), as well as those 
developed by trusts to operationalise improvement efforts 
and recommendations from the regulator. For example, we 
will examine relevant meeting minutes (eg, board meetings 
and operational units), strategic performance documents and 
business plans to help triangulate findings from interviews 
and observations. 
(ii) The Use of Data by Trusts
To complement the qualitative analysis, we will look deeper 
into the way data are being used by case study trusts, focussing 
specifically on how they monitor the impact of interventions 
and track quality improvements and whether they perceive 
that they have the capabilities and resources to do so 
effectively. We will also assess any changes in the way trusts 
use data once being placed into special measures or identified 
as “challenged,” including investing resources to support 
more accurate data collection and monitoring. Moreover, we 
will analyse whether, and how, trusts track progress against 
required improvements and these examples could offer 
helpful insights into whether trusts will be resilient to future 
challenges.
This work will link with the qualitative analysis described 
above in that trust interviews will provide on-the-ground 
insight into how being in special measures, or on the challenged 
provider list, influences their approach to the collection of 
data and how they monitor quality. They may also provide 
 
 
• SMQ or CP trusts that later 
achieve strong CQC report 
with no re-entry (n=2)
• CP trusts that never enter 
SMQ (n=2)
• Providers who leave CP and 
enter SMQ (n=2)
• At least 2 years in SMQ, 
includes trusts that re-enter 
SMQ (n=2) Prolonged 
poor 
performers 
(SMQ)
Poor 
performers 
(CP + SMQ)
Clear 
performance 
improvers (CP 
+ SMQ)
Shorter-term 
challenged 
providers (CP)
Figure 2. Purposive Sampling Model for Case Studies. Abbreviations: SMQ, Special Measures for Quality; CP, Challenged Providers; CQC, Care 
Quality Commission.
Table 4. Summary of Qualitative and Quantitative Data Collection at In-Depth vs. High-Level Sites
In-Depth Sites High-Level Sites
Qualitative Components
Non-participant observation (eg, board meetings, 
operational meetings)
Yes 
Number of observations: 2 at each site (8 in total)
No
Interviews Yes Yes
Participants: from across different organisational 
tiers + external stakeholders
Sample size: 15 interviews at each site (60 in 
total)
Participants: from the top of the 
organisation + key external stakeholders
Sample size: 8-10 interviews at each sites 
(32-40 in total)
Documentary analysis Yes Yes
Quantitative Components
Trust use of quantitative information relating to quality 
of care
Yes Yes
Tracking of outcome measures against improvement 
actions
Yes No
Trust use of metrics to monitor impact of SMQ regime 
and challenged provider interventions
Yes Yes
Abbreviation: SMQ, Special Measures for Quality.
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details on specific measures they are using and the qualitative 
interview topic guides will include questions focused on 
the trust’s use of information. Additional interviews will be 
conducted if necessary to gather specific information on data 
collection and monitoring of quality.
Other sources of information will be CQC inspection 
reports, documents produced by, or on behalf of, trusts (eg, 
Board reports, Quality Accounts), NHSI monthly monitoring 
of trusts and changes in their performance (eg, NHSI Single 
Oversight Framework segmentation) and, for wider context, 
the findings of the rapid literature review. These, in turn, may 
produce further lines of enquiry that could be followed up 
with the case study sites.
The analysis will include monitoring relevant improvement 
actions highlighted by these documents where they can 
be appropriately linked to outcomes observed in data. For 
example, if CQC raised concerns about a stroke service, 
then we would be interested in how the trust used data to 
track outcomes and to provide assurance that the quality of 
the stroke service is improving. There may also be evidence 
to suggest that pressures on some outcomes are related to 
performance of other providers in the local health system 
which we will investigate, where feasible. For some measures, 
data would be available to put the trust’s changes in outcomes 
within a national context, and possible sources include 
material published by the trusts (eg, Board papers), published 
statistics and patient-level records from Hospital Episode 
Statistics and national monitoring reports produced by NHSI 
(eg, monthly Single Oversight Framework segmentation 
spreadsheets). (Note: we have approval from NHS Digital 
covering all projects conducted by the REST.)
(iii) Case Study Data Analysis
Triangulation of interview, observational, documentary and 
quantitative data will produce 8 local case studies that will 
be analysed thematically and comparatively, consistent with 
suggestions in academic literature on analysing processes 
of change in organisations25-27 and on receptive contexts for 
sustaining quality improvement in healthcare.28,29 
4. Exploratory Workforce Evaluation
This additional quantitative component will explore 
relationships between workforce data and being in SMQ or on 
the challenged providers list. We will explore whether trusts 
find it more difficult to recruit and retain staff, or whether 
staff turnover increases after entering SMQ/challenged 
provider regimes. This will require trust-level workforce 
recruitment, retention, and turnover data from NHS Digital 
and information on vacancies and agency staff from NHSI. 
These data will be combined with trust inspection information 
from CQC, and details of time spent in any quality regime. 
Additional trust information such as size, financial situation, 
teaching status, measures of underlying patient need, 
or rurality will be considered. This proposed analysis is 
exploratory and subject to construction of a consistent and 
comparable workforce dataset and sufficient sample sizes to 
establish any statistical links. In any event we will be able to 
raise hypotheses that could be tested more robustly in future 
studies and reflected back to the case study sites for their 
qualitative insights.
5. Economic Analysis
The economic analysis aims to quantify the costs and benefits 
of different combinations of interventions used in SMQ/
challenged provider regimes from an NHS perspective, 
using a cost-consequence analysis (CCA) approach. A 
CCA compares interventions in which the components of 
incremental costs (direct or indirect) and consequences (eg, 
knowledge, behaviours, processes) are computed and listed, 
without aggregating these results into a cost-effectiveness 
ratio.30 This approach enables one to look into process 
measures and qualitative findings in a quantitative manner, 
allowing for some insight as to how potential benefits compare 
to the cost of interventions.
A feasibility study for the economic analysis found that:
1. A CCA was feasible, but it would only be possible to 
evaluate different combinations of interventions, ie, it 
would not be possible to evaluate the benefits of each 
intervention individually. It would need to account 
for likely variation in the type and intensity of these 
interventions, eg, percentage of full-time equivalent 
(FTE) time the Improvement Director spends at the 
trust, different buddying models, varying receipt of funds 
spent in different ways. We will explore the impact of this 
variation on both costs and consequences. 
2. Costs could be measured using resource use and unit 
cost data collected during the multi-site mixed methods 
study.
3. Consequences could be measured using qualitative data 
collected during the multi-site mixed methods study 
and/or combining it with quantitative data.
Cost Analysis
The first component of the economic analysis consists of a 
cost analysis, which is feasible as a standalone analysis, as it 
does not depend on qualitative findings from the case studies 
or quantitative analysis. 
Each intervention will be costed using data collected during 
the case studies. We will calculate the costs of appointing an 
external Improvement Director based on salary costs plus 
other costs incurred, accounting for whether and how these 
costs may be shared across different trusts. We will identify 
the activities that typically occur with different models of 
buddying (eg, meetings, site visits, etc), and calculate the 
costs of these different models, including costs incurred by 
both the trust in SMQ and the ‘buddy’ trust. We will obtain 
information on the funds received to support improvement 
(challenged providers may access up to £200 000, while SMQ 
trusts may access up to £500 000), and identify how these 
monies, when received, are spent. For each intervention, 
we will also identify where the cost is incurred. We will also 
include opportunity costs as perceived by SMQ/challenged 
providers from an NHS perspective. 
Cost-Consequence Analysis
Based on the qualitative findings from the case studies, we 
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aim to conduct a CCA that will evaluate the consequences 
of different combinations of interventions, considering type/
intensity, and compare these with their costs. Consequences 
will be measured using qualitative data collected from the 
case studies, based on recurrent topics raised in the case 
studies’ emerging findings. These will be transformed 
into a meaningful scale, to quantify relative impacts of the 
intervention combinations. This approach allows for the 
findings of the process evaluation to be understood as a 
relative impact, which can be balanced against costs. 
As there is likely to be between-trust variation in the type 
and intensity of the 3 main interventions, we will explore 
how consequences vary by type and intensity. Given that the 
measurement of both costs and consequences will depend on 
data collection from the case studies, the economic analysis 
will take place in 2 phases: (1) a cost analysis to take place in 
the initial months following access to selected NHS trusts and 
(2) a CCA following data collection in the case studies. 
Patient and Public Involvement 
Two patient representatives provided feedback on the protocol 
and will provide ongoing review and feedback throughout 
the study (including dissemination). We presented the 
study topic to a local Research Advisory Panel, comprising 
patient representatives and members of the public. The 
Research Advisory Panel will provide programme level 
involvement, as distinct from individual evaluation-level and 
engagement activity. The Research Advisory Panel feedback 
informed protocol development, and additional feedback 
will be requested throughout the study. We will devise a 
local involvement and engagement strategy and when the 
site sample is defined, we will contact local patient groups, or 
individual key informers to obtain their views. 
Discussion
This mixed methods study will enable an analysis of the 
SMQ/challenged providers regimes and the interventions 
within them that have been set out by NHSI from the 
point of view of a wide range of stakeholders and multiple 
participating sites. The proposed research will inform our 
understanding of how trusts respond to the interventions and 
how they may impact on organisations’ capacity to achieve 
and sustain quality improvements over time. We will also 
gain insights into staff views and experiences with processes 
of change and improvement. Undertaking case studies of sites 
experienced with the SMQ/challenged provider regimes is a 
central component of the proposal. In addition to facilitating 
an analysis of the interventions delivered by NHSI, using a 
case study approach will also allow us to remain mindful that 
additional interventions may be deployed, and significant 
changes to leadership are frequently concurrent.
We anticipate generating lessons for trusts on responding 
to the interventions, such as what to prioritise and the 
organisational capabilities that have been found to support 
quality improvement. There will also be lessons for national 
bodies on how to support these trusts in light of the varied 
internal and external contexts of healthcare organisations 
facing performance difficulties. The information gathered in 
this study will also lead to recommendations on using routine 
and quantitative data to track quality improvements, including 
at system level, and set out the potential costs and benefits 
of individual interventions in the SMQ/challenged provider 
regimes. Research examining the interventions delivered by 
NHSI is limited and another key output from the study will be 
a conceptual framework that will to help evaluate the SMQ/
challenged provider regimes in future. Our findings may also 
have wider applications to other regulated contexts, such as 
the education sector, and public sector management theory 
more broadly. 
A key strength of the study is the mixed method approach 
that comprises a literature review, in-depth case studies, 
quantitative analyses that will be responsive to emerging 
themes from the case studies, and consideration of costs and 
potential consequences in an economic evaluation. There are, 
however, some potential limitations. The study duration of 
one year means that we will only have a partial view of the 
process and cannot study developments within the 8 case 
studies and their strategic responses to performance issues 
longitudinally. In addition, some data will be retrospective. 
It is also possible that access to case study sites may be 
constrained due to the sensitive nature of the research topic. 
The number of case-study sites may make it difficult to draw 
general conclusions about use of data, although our sampling 
is in line with many other high quality examples of case 
study research which apply mixed methods, and may have 
fewer than 8 organisations to compare. Within the trusts 
themselves, there may be problems accessing relevant data 
in which case we aim to be pragmatic and work with what 
we can obtain from national and publicly available datasets. 
Finally, the economic component of the study will not be able 
to disentangle individual effects from each intervention due 
to the complex nature and implementation unique to each 
participating site.
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